3 Undervalued Pharmaceuticals Stocks for Wednesday, July 15
Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, July 15 based on AAII’s Stock Grades.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Michael Rose
Tudor Pop
| Share Statistics | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $397.7 | $579.1 | 35% |
|
| Shares Out (Mil) | 72.7 | 43.0 | 56% |
|
| Institutional Ownership | 33.7% | 84.3% | 15% |
|
| Float (Mil) | 65.3 | 46.8 | 53% |
|
| Beta | 1.39 | 0.62 | 79% |
|
| Avg Daily Volume (000s) | 91 | 285 | 35% |
|
| Price Change (52-week) |
83.4% | 63.8% | 89% |
|
| Growth | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 29.2% | 6.7% | 89% |
|
| Net Income (5yr) | (54.2%) | (1.4%) | 6% |
|
| EPS (5yr) | (48.0%) | 14.9% | 4 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.8%) | (14.9%) | 36% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | na | na | |
| Current EPS | ($0.300) | na | na | |
| Month Ago EPS | ($0.300) | na | na | |
| # Rev Up | 0 | na | na | |
| # Rev Down | 0 | na | na | |
| Three Months Ago EPS | ($0.300) | na | na | |
| Year/Year Chg | 20.0% | na | (101.2%) | |
| Financials | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $820 | $272 | 48% |
|
| Net Income (TTM) (Mil) | ($264) | ($11) | 5% |
|
| EPS (TTM) | ($3.650) | ($0.500) | 10% |
|
| Operating Cash Flow (TTM) (Mil) | $70 | ($6) | 49% |
|
| Net Cash Flow (TTM) (Mil) | ($10) | $4 | 30% |
|
| Long-Term Debt (Q1) (Mil) | $473 | $7 | 58% |
|
| Enterprise Value (Q1) (Mil) | $864 | $522 | 40% |
|
| Valuation | VRNO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.58 | 2.73 | 11% |
|
| P/E | na | 20.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 50.4% | 65.9% | 62% |
|
| Net Margin | (32.2%) | 0.7% | 14% |
|
| ROA | (14.4%) | (24.6%) | 23% |
|
| ROE | (32.4%) | (19.7%) | 19% |
|
| Liabilities to Assets | 59.8% | 35.5% | 54% |
|
| F-Score | 6 | 3 | 69% |
|
Verano Holdings Corp. did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors